Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 129.1% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Apogee Therapeutics is a clinical-stage biotechnology compa
Yahoo
The consensus price target hints at a 132.7% upside potential for Apogee Therapeutics Inc. (APGE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Finnhub
SAN FRANCISCO, BOSTON - Apogee Therapeutics, Inc., , a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory...
Yahoo
Apogee Therapeutics, Inc. (NASDAQ:APGE) on Monday revealed interim data from its Phase 1b trial of APG808, a novel half-life extended IL-4Rα antibody, in patients with mild-to-moderate asthma. The Phase 1b double-blind, placebo-controlled, multiple-dose trial evaluated the safety and tolerability of APG808 in 22 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide concentration (FeNO), TARC, and pSTAT6. Participants were randomized 3:1, receiving
SeekingAlpha
Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma treatment. Click for my APGE stock update.
Current Value
$44.121 Year Return
Current Value
$44.121 Year Return
Double maintains 1 strategies that include APGE - Apogee Therapeutics, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -35.91% | $165.58M | 0.85% |
| BTAL | -35.36% | $295.67M | 1.43% |
| TAIL | -34.86% | $99.49M | 0.59% |
| IVOL | -15.26% | $348.25M | 1.02% |
| FXY | -14.26% | $820.31M | 0.4% |
| CTA | -11.75% | $1.06B | 0.76% |
| ULST | -9.26% | $658.54M | 0.2% |
| SPTS | -8.00% | $5.77B | 0.03% |
| SHYM | -7.85% | $354.58M | 0.35% |
| STOT | -7.76% | $253.88M | 0.45% |
| XONE | -7.69% | $585.85M | 0.03% |
| KCCA | -7.33% | $105.90M | 0.87% |
| UTWO | -6.49% | $379.27M | 0.15% |
| STPZ | -6.19% | $450.05M | 0.2% |
| TPMN | -5.65% | $30.70M | 0.65% |
| FTSD | -4.79% | $231.68M | 0.25% |
| SCHO | -4.64% | $11.46B | 0.03% |
| BSMW | -4.37% | $107.29M | 0.18% |
| VGSH | -4.33% | $22.77B | 0.03% |
| VTIP | -4.01% | $15.34B | 0.03% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SYRE | 54.39% | $934.88M | -34.89% | 0.00% |
| CRNX | 53.00% | $2.66B | -37.57% | 0.00% |
| ATXS | 50.96% | $306.44M | -39.46% | 0.00% |
| KRYS | 50.39% | $4.02B | -21.73% | 0.00% |
| NRIX | 49.61% | $892.72M | -38.14% | 0.00% |
| OCUL | 49.59% | $1.45B | +36.23% | 0.00% |
| IDYA | 49.37% | $1.85B | -37.37% | 0.00% |
| CLDX | 49.11% | $1.41B | -42.69% | 0.00% |
| DYN | 48.43% | $986.63M | -74.95% | 0.00% |
| RCUS | 48.32% | $885.20M | -42.94% | 0.00% |
| DNLI | 48.31% | $2.03B | -35.83% | 0.00% |
| CGON | 48.01% | $2.01B | -15.87% | 0.00% |
| BEAM | 46.60% | $1.76B | -22.33% | 0.00% |
| ACLX | 46.46% | $3.56B | +21.48% | 0.00% |
| IMNM | 46.23% | $736.56M | -27.65% | 0.00% |
| ELVN | 45.91% | $1.16B | -9.45% | 0.00% |
| IRON | 45.32% | $1.77B | +22.85% | 0.00% |
| RVMD | 45.22% | $6.87B | -1.31% | 0.00% |
| XNCR | 44.34% | $574.35M | -55.81% | 0.00% |
| XENE | 43.89% | $2.46B | -12.23% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| K | -13.75% | $27.71B | +40.85% | 2.85% |
| CBOE | -13.53% | $24.29B | +35.36% | 1.09% |
| PULM | -12.80% | $24.14M | +230.50% | 0.00% |
| STG | -12.26% | $30.47M | -21.87% | 0.00% |
| VSTA | -8.38% | $341.66M | +42.00% | 0.00% |
| AGL | -7.95% | $985.21M | -59.52% | 0.00% |
| WBA | -6.82% | $9.95B | -0.69% | 4.36% |
| VHC | -6.21% | $48.79M | +87.46% | 0.00% |
| UUU | -5.23% | $6.98M | +97.39% | 0.00% |
| RILY | -5.01% | $97.90M | -80.90% | 0.00% |
| VSA | -4.57% | $8.76M | -18.25% | 0.00% |
| NEUE | -4.46% | $61.16M | +29.25% | 0.00% |
| AQB | -4.46% | $2.87M | -53.40% | 0.00% |
| ED | -4.30% | $36.31B | +13.27% | 3.35% |
| LITB | -4.28% | $22.07M | -77.41% | 0.00% |
| KO | -4.12% | $308.49B | +13.49% | 2.78% |
| MO | -3.90% | $97.93B | +26.25% | 6.95% |
| IMNN | -3.43% | $15.87M | -37.00% | 0.00% |
| CME | -3.29% | $99.25B | +39.75% | 3.87% |
| BTCT | -3.04% | $22.63M | +43.33% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| MLN | -0.03% | $540.39M | 0.24% |
| BWX | -0.10% | $1.53B | 0.35% |
| FXE | 0.16% | $578.76M | 0.4% |
| IBTL | 0.17% | $379.97M | 0.07% |
| JPLD | 0.24% | $1.76B | 0.24% |
| JMST | 0.27% | $4.06B | 0.18% |
| IBTK | 0.28% | $441.97M | 0.07% |
| USDU | -0.29% | $163.19M | 0.5% |
| STIP | -0.31% | $12.70B | 0.03% |
| VGIT | -0.31% | $31.79B | 0.04% |
| AGGH | 0.37% | $322.91M | 0.29% |
| IBTM | 0.41% | $315.47M | 0.07% |
| UUP | 0.41% | $209.45M | 0.77% |
| IBMN | 0.41% | $446.95M | 0.18% |
| BILS | -0.51% | $3.83B | 0.1356% |
| IBTJ | -0.52% | $684.86M | 0.07% |
| DFNM | 0.55% | $1.57B | 0.17% |
| IBTG | -0.58% | $1.92B | 0.07% |
| SPTI | 0.81% | $8.80B | 0.03% |
| SCHR | 0.96% | $11.10B | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 64.02% | $4.84B | 0.35% |
| IBB | 57.10% | $5.28B | 0.45% |
| PBE | 55.92% | $223.86M | 0.58% |
| GNOM | 55.25% | $44.38M | 0.5% |
| ARKG | 51.09% | $1.02B | 0.75% |
| IWO | 49.87% | $11.53B | 0.24% |
| BBH | 49.75% | $329.37M | 0.35% |
| IWC | 49.74% | $817.74M | 0.6% |
| FBT | 49.72% | $1.01B | 0.54% |
| PINK | 49.18% | $129.96M | 0.5% |
| VTWO | 48.21% | $12.58B | 0.07% |
| IWM | 48.00% | $63.18B | 0.19% |
| KJUL | 47.54% | $119.28M | 0.79% |
| SCHA | 47.22% | $17.26B | 0.04% |
| PTH | 46.87% | $100.70M | 0.6% |
| NUSC | 46.49% | $1.14B | 0.31% |
| ISCG | 46.35% | $679.46M | 0.06% |
| KJAN | 46.17% | $287.49M | 0.79% |
| VBK | 45.73% | $18.99B | 0.07% |
| FYX | 45.69% | $820.40M | 0.6% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -0.04% | $90.90B | +24.44% | 0.39% |
| SYPR | -0.18% | $46.42M | +9.19% | 0.00% |
| PPC | 0.28% | $10.79B | +32.45% | 0.00% |
| PARAA | -0.37% | $15.30B | +17.49% | 0.88% |
| MSIF | -0.49% | $756.27M | +33.83% | 7.70% |
| ALHC | 0.67% | $2.81B | +80.33% | 0.00% |
| GFI | 0.68% | $21.24B | +58.84% | 2.32% |
| DFDV | 0.79% | $309.70M | +2,106.40% | 0.00% |
| COR | 1.09% | $57.24B | +32.73% | 0.74% |
| T | 1.17% | $207.81B | +53.45% | 3.83% |
| UTZ | 1.19% | $1.13B | -19.50% | 1.85% |
| KMB | 1.24% | $43.67B | -4.62% | 3.76% |
| EXC | -1.30% | $43.82B | +25.72% | 3.63% |
| CVS | 1.33% | $88.02B | +20.97% | 3.92% |
| AEP | -1.60% | $55.76B | +19.14% | 3.55% |
| SO | 1.60% | $101.44B | +19.02% | 3.16% |
| PHYS.U | 1.79% | - | - | 0.00% |
| ARLP | 1.81% | $3.32B | +2.62% | 10.80% |
| HIHO | 1.92% | $7.26M | -20.67% | 4.19% |
| PRPO | 1.95% | $16.51M | +118.40% | 0.00% |
